CAMK2 Therapeutics Network

The CAMK2 Therapeutics Network is a family-led, collaborative research initiative dedicated to improving the lives of individuals affected by CAMK2 gene-related disorders.

We are committed to supporting the CAMK2 Community through:

1) Educating families, clinicians, and scientists

2) Expanding access to diagnosis, research, and expert care

3) Accelerating treatments through strategic partnerships.

Our relentless goal: relieve symptoms and enhance quality of life for every affected individual worldwide.

CAMK2 is a group of four genes that play a key role in how the brain and heart function. These genes send instructions to the body to make proteins that help nerve cells communicate and support overall development. When there’s a change, or variant, in one of these genes, it can affect how those proteins work, which can lead to CAMK2-related disorders.

CAMK2-related disorders can show up in many ways, and symptoms can be different for each person. Common challenges include developmental delays, learning difficulties, seizures, low muscle tone, trouble with movement or coordination, speech or language delays, and behavioral differences. Scientists are still learning how these gene changes affect people over time. Ongoing studies are helping researchers understand each variant better and work toward new treatments and support for families.